Keyword

rigosertib

Description: An investigational anticancer drug that inhibits cellular signaling pathways and has been studied for malignancies and other disease processes.
Wikidata ID: wiki/Q21099552
OpenAlex ID: keywords/rigosertib
2016 · Sai Krishna Athuluri-Divakar, Rodrigo Vasquez-Del Carpio, et al. · Cell · 293
2022 · Reza Ahmadi, Saeed Emami · European Journal of Medicinal Chemistry · 145
2016 · Daniel A. Ritt, María T. Abreu-Blanco, et al. · Molecular Cell · 125
2020 · Michael J. Duffy, John Crown · International Journal of Cancer · 94
2014 · G Montalban-Bravo, G Garcia-Manero · Leukemia · 91
2020 · Marco Jost, Yuwen Chen, et al. · Molecular Cell · 61
2013 · Rami S. Komrokji, Azra Raza, et al. · British Journal of Haematology · 61
2018 · Azad Saei, Marta Palafox, et al. · The Journal of Experimental Medicine · 58
2013 · Lohith Bachegowda, Oleg Gligich, et al. · Journal of Hematology & Oncology · 58
Works count: 299
Citation count: 3,721
Year
Topic
Type